Chronic cough and cough hypersensitivity: from mechanistic insights to novel antitussives.

Competing Interests: SBM holds grants from the Australian Research Council and the National Health and Medical Research Council of Australia; he declares honoraria from Merck, NeRRe Therapeutics, Reckitt Benckiser, and Bellus Health, and grant support from Merck and Bellus Health. IS is currently supported by the EJ Moran Campbell Early Career Award from the Department of Medicine, McMaster University (Hamilton, ON, Canada); he is the recipient of a European Respiratory Society RESPIRE3 Marie Sklodowska-Curie fellowship and he declares grants and personal fees from Merck Canada and GlaxoSmithKline (GSK), grants from Bayer and Bellus, and personal fees from Respiplus, Genentech, and AstraZeneca. LM reports grant support from Merck, and honoraria for lectures and advisory board participation from Chiesi, GSK, Merck, NeRRe Therapeutics, Shionogi, AstraZeneca, Nocion, Boehringer Ingelheim, and Reckitt Benckiser. W-JS declares grants from Merck and AstraZeneca, consulting fees from Merck, AstraZeneca, Shionogi, and GSK, and lecture fees from Merck, AstraZeneca, GSK, and Novartis. KFC has received honoraria from GSK, AstraZeneca, Novartis, Merck, Nocion, Shionogi, and Reckitt Benckiser for advisory board participation, and from Haleon for scientific advisory board participation for the Clean Breathing Institute; he has also been remunerated for speaking engagements by AstraZeneca, Novartis, and Merck. KFC is supported by grants from the UK Medical Research Council and Engineering Physical Sciences Research Council, and is Senior Investigator of the UK National Institute for Health Research. The Twelfth London International Cough Symposium was supported by an educational grant from Merck, with contributions from Bellus Health, Bionorica, NeRRe Therapeutics, Nocion Therapeutics, Reckitt Benkiser, Shionogi, and Trevi Therapeutics. The funders had no role in developing the programme for the Symposium.